A preliminary finding reported by ScienceDaily points to an enzyme that helps liver cells manage damaged mitochondria and fat, potentially limiting progression to MASH.
Researchers have identified an enzyme called UBE2N that appears to act as a natural brake on the worsening of fatty liver disease, a condition estimated to affect 100 million Americans, according to ScienceDaily. The enzyme is reported to help liver cells clear away damaged mitochondria and break down excess fat, two processes linked to disease progression.
In outline, the work links UBE2N activity to the liver's ability to manage cellular waste and fat storage, which in turn may reduce the inflammation, scarring and cell damage seen in the more severe form of the disease known as MASH, as described by the outlet.
ScienceDaily's report does not specify the experimental model used, for instance whether the work was done in human liver tissue, animal models or cell cultures, nor does it state how far these findings are from clinical application. This is a preliminary finding and the underlying study has not been reviewed here in full.
Clinicians and students should treat this as an early mechanistic lead rather than a therapy. It identifies a candidate pathway, UBE2N-related clearance of damaged mitochondria and fat, that may be worth monitoring as more detailed, peer-reviewed data become available.
Based on reporting by ScienceDaily
This protective enzyme could help stop fatty liver disease from getting worse, 2026-10-03. The Gufo links to the report and does not reproduce it.
